Business Context and Reporting Period
Company: Organogenesis Holdings Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 9, 2020
Reporting Period: Third fiscal quarter ended September 30, 2020, and the nine months ended September 30, 2020.
Context: The filing announces the release of financial results for the specified periods via a press release incorporated by reference as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the referenced press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific details on material changes versus prior periods. It only confirms that results for the third quarter and nine months of 2020 have been announced.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release containing the financial results but does not include the text of the commentary, guidance, or outlook.
Risks and Contingencies: No specific risks or contingencies are detailed in this excerpt.
Unusual Items: None identified in the provided text.
Investor Verification Checklist
- Review the full text of the press release (Exhibit 99.1) to obtain specific revenue, net income, and cash flow figures for Q3 and the nine months ended September 30, 2020.
- Verify year-over-year comparisons and management's discussion of financial condition in the referenced exhibit.
- Check for any forward-looking statements or updated guidance included in the press release.
- Confirm the status of the company as an Emerging Growth Company (indicated as "Yes" in the filing).